Lifecore Biomedical Inc — Cash Flow (NASDAQ:LFCR) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities 15.02 M-24.4 M-17.44 M-217 K-206 K 2.17 M Cash from investing activities -10.86 M81.77 M-4.81 M-17.92 M-6.42 M -4.73 M Cash from financing activities -3.42 M-57.02 M39.7 M7.51 M6.42 M 3.94 M Free cash flow -8.75 M-50.63 M-17.44 M-217 K-13.62 M -9.56 M

Haberler

Lifecore Biomedical beş ayda üçüncü tesis transferi anlaşması imzaladı

Jobs Data, PMI In Focus With A Muted Earnings Calendar Next Week

Lifecore Biomedical, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:LFCR) 2026-03-16

Lifecore Biomedical kazancı beklentilere göre daha kötü, kâr ise beklentilere göre düşük

Lifecore Biomedical earnings missed, revenue fell short of estimates

Lifecore, Indomo için akne tedavisi üretecek

Lifecore to manufacture acne treatment batches for Indomo

Lifecore Biomedical: Wins Should Blow Previous 'New Business' Estimates Out Of The Water (undefined:LFCR)

Lifecore Biomedical: The Turnaround Is Just Getting Started (NASDAQ:LFCR)

KeyBanc, Lifecore Biomedical hissesi için Sektör Ağırlığı notunu korudu

KeyBanc maintains Sector Weight rating on Lifecore Biomedical stock

FOMC Minutes, Initial Jobless Claims In Focus